Publications by authors named "Marion Huchet"

Claim this Profile
B
Botulinum Neurotoxins Serotypes A and B induce paralysis of mouse striated and smooth muscles with different potencies.
Jacquie Maignel-Ludop, Marion Huchet, Johannes Krupp

Pharmacol Res Perspect· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel inhibitors of 17beta-hydroxysteroid dehydrogenase type 1: templates for design.
Gillian M Allan, Nigel Vicker, Harshani R Lawrence, Helena J Tutill, Joanna M Day, Marion Huchet

Bioorg Med Chem· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Butyl 2-(4-[1.1'-biphenyl]-4-yl-1H-imidazol-2-yl)ethylcarbamate, a potent sodium channel blocker for the treatment of neuropathic pain.
Anne-Marie Liberatore, Jocelyne Schulz, Christine Favre-Guilmard, Jacques Pommier, Jacques Lannoy, Marion Huchet

Bioorg Med Chem Lett· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticancer activity of BIM-46174, a new inhibitor of the heterotrimeric Galpha/Gbetagamma protein complex.
Grégoire P Prévost, Marie O Lonchampt, Susan Holbeck, Samir Attoub, Daniel Zaharevitz, Marion Huchet

Cancer Res· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2-Alkyl-4-arylimidazoles: structurally novel sodium channel modulators.
Anne-Marie Liberatore, Jocelyne Schulz, Jacques Pommier, Marie-Anne Barthelemy, Marion Huchet

Bioorg Med Chem Lett· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BN80927: a novel homocamptothecin that inhibits proliferation of human tumor cells in vitro and in vivo.
Danièle Demarquay, Marion Huchet, Helène Coulomb, Laurence Lesueur-Ginot, Olivier Lavergne

Cancer Res· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis